Domestic pharma player

Targeting high-potential therapeutic areas to drive growth

- 

Corona Remedies is an India-focused branded pharmaceutical formulation company developing, manufacturing and marketing products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas.

As of June 30, 2025, the diverse portfolio included 71 brands across therapeutic areas. Women’s healthcare brands span the entire lifecycle, from adolescence to infertility, pregnancy, post-pregnancy, and pre and post menopause. In cardio-diabeto, it provides treatments across all stages of diabetes, from insulin resistance and pre-diabetes to diabetes and related complications. In pain management, the portfolio includes four dosage forms, including tablets, capsules, sprays and injections. While in urology, brands address multiple disorders, including benign prostatic hyperplasia, overactive bladder, urinary tract infections and stone management.

There are two manufacturing facilities, located in Gujarat and Himachal Pradesh. Manufacturing facilities were spread over an aggregate of 2.83 hectares and had an aggregate installed capacity for formulations of 1,285.44 million units per annum, with a total of 11 production lines, end June 2025. It is in the process of commissioning a hormone manufacturing facility in Gujarat in Q1 FY 2027.

The pan-India marketing and distribution network comprises 2,671 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas.